R

ise and shine, everyone, another busy day is on the way. We could tell because our short person rushed out the door to grab a ride to the local schoolhouse and we have already quaffed two cups of stimulation — French toast is our preference, for those tracking such things. All this means that the time has come to attack the ever-growing to-do list. So join us as we dig in. Speaking of which, here are some tidbits. Hope your day is outstanding …

The World Health Organization hopes to conduct a “full review” by the end of the year of data on the Sanofi (SNY) dengue vaccine, Reuters reports. The move comes after the company said a new analysis found its Dengvaxia vaccine could actually make future cases of the mosquito-borne virus more severe in people who were not previously infected. The issue arises after a pair of scientific papers published over the past two years suggested such a problem with the vaccine.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy